Effects of Cohort Selection on the Results of Cost-Effectiveness Analysis of Disease-Modifying Drugs for Relapsing-Remitting Multiple Sclerosis

Disease Modifying Drugs ◽

Effectiveness Analysis ◽

Cohort Selection ◽

Relapsing Remitting ◽

Disease Modifying ◽

Peginterferon beta-1a versus other self-injectable disease-modifying therapies in the treatment of relapsing-remitting multiple sclerosis in Scotland: a cost-effectiveness analysis

Journal of Medical Economics ◽

10.1080/13696998.2016.1247712 ◽

2016 ◽

Vol 20 (3) ◽

pp. 228-238 ◽

Cited By ~ 10

Author(s):

Luis Hernandez ◽

Shien Guo ◽

Hector Toro-Diaz ◽

Stuart Carroll ◽

Syed Feisal Syed Farooq

Keyword(s):

Multiple Sclerosis ◽

Cost Effectiveness ◽

Effectiveness Analysis ◽

Disease Modifying Therapies ◽

Relapsing Remitting ◽

Disease Modifying ◽

Cost-Effectiveness Analysis of Peginterferon Beta-1a Vs. First-Line Injectable Disease-Modifying Therapies For The Treatment of Relapsing-Remitting Multiple Sclerosis In Spain

Value in Health ◽

10.1016/j.jval.2017.08.1948 ◽

2017 ◽

Vol 20 (9) ◽

pp. A723

Author(s):

L Ruiz ◽

H Toro-Diaz ◽

C Cele ◽

L Hernandez ◽

A Harrington

Keyword(s):

Multiple Sclerosis ◽

Cost Effectiveness ◽

First Line ◽

Effectiveness Analysis ◽

Disease Modifying Therapies ◽

Relapsing Remitting ◽

Disease Modifying ◽

PND51 Cladribine Tablets (CT) Versus Other Disease-Modifying Therapies in the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) - Cost-Effectiveness Analysis.

Value in Health ◽

10.1016/j.jval.2020.08.1376 ◽

2020 ◽

Vol 23 ◽

pp. S632

Author(s):

P. Zięba ◽

D. Pawlik ◽

J. Wieczorek ◽

R. Wojcik ◽

M.P. Kaczor

Keyword(s):

Multiple Sclerosis ◽

Cost Effectiveness ◽

Effectiveness Analysis ◽

Disease Modifying Therapies ◽

Relapsing Remitting ◽

Disease Modifying ◽

Cost-Effectiveness Analysis of Cladribine Tablets for Treatment of Patients with Relapsing-Remitting Multiple Sclerosis in Bulgaria

Value in Health ◽

10.1016/j.jval.2018.04.1403 ◽

2018 ◽

Vol 21 ◽

pp. S206 ◽

Cited By ~ 1

Author(s):

S Djambazov ◽

G Slavchev ◽

T Dineva ◽

P Panayotov ◽

T Vekov

Keyword(s):

Multiple Sclerosis ◽

Cost Effectiveness ◽

Effectiveness Analysis ◽

Relapsing Remitting ◽

Cost-effectiveness analysis of escalating to natalizumab or switching among immunomodulators in relapsing-remitting multiple sclerosis in Italy

BMC Health Services Research ◽

10.1186/s12913-019-4264-1 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 1

Author(s):

Gianluca Furneri ◽

Laura Santoni ◽

Chiara Ricella ◽

Luca Prosperini

Keyword(s):

Multiple Sclerosis ◽

Cost Effectiveness ◽

Effectiveness Analysis ◽

Relapsing Remitting ◽

PND8 COST-EFFECTIVENESS ANALYSIS OF REBIF IN FIRST-LINE RELAPSING REMITTING MULTIPLE SCLEROSIS IN GERMANY

Value in Health ◽

10.1016/s1098-3015(10)66969-0 ◽

2008 ◽

Vol 11 (6) ◽

pp. A602

Author(s):

MJ Nuijten ◽

T Mittendorf ◽

A Jäcker ◽

U Osowski

Keyword(s):

Multiple Sclerosis ◽

Cost Effectiveness ◽

First Line ◽

Effectiveness Analysis ◽

Relapsing Remitting ◽

Cost-effectiveness analysis of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis

Journal of Medical Economics ◽

10.3111/200104207219 ◽

2001 ◽

Vol 4 (1-4) ◽

pp. 207-219 ◽

Cited By ~ 9

Author(s):

Uday Bose ◽

David Ladkani ◽

Anita Burrell ◽

Mohammad Sharief

Keyword(s):

Multiple Sclerosis ◽

Cost Effectiveness ◽

Glatiramer Acetate ◽

Effectiveness Analysis ◽

Relapsing Remitting ◽

PND2 TREATMENTS FOR HIGHLY ACTIVE RELAPSING REMITTING MULTIPLE SCLEROSIS: COST-EFFECTIVENESS ANALYSIS IN COLOMBIA

Value in Health Regional Issues ◽

10.1016/j.vhri.2019.08.332 ◽

2019 ◽

Vol 19 ◽

pp. S59

Author(s):

P. Lasalvia ◽

Y. Gil Rojas ◽

F. Hernández ◽

C. Castañeda-Cardona ◽

D. Rosselli

Keyword(s):

Multiple Sclerosis ◽

Cost Effectiveness ◽

Highly Active ◽

Effectiveness Analysis ◽

Relapsing Remitting ◽

Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Scotland

Value in Health ◽

10.1016/j.jval.2015.09.2933 ◽

2015 ◽

Vol 18 (7) ◽

pp. A756

Author(s):

L Hernandez ◽

S Guo ◽

H Toro-Diaz ◽

S Carroll ◽

SF Syed Farooq

Keyword(s):

Multiple Sclerosis ◽

Cost Effectiveness ◽

Effectiveness Analysis ◽

Relapsing Remitting ◽

Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Ireland

Value in Health ◽

10.1016/j.jval.2015.09.2460 ◽

2015 ◽

Vol 18 (7) ◽

pp. A756

Author(s):

L Hernandez ◽

S Guo ◽

H Toro-Diaz ◽

S Carroll ◽

SF Syed Farooq

Keyword(s):

Multiple Sclerosis ◽

Cost Effectiveness ◽

Effectiveness Analysis ◽

Relapsing Remitting ◽